M.D. Harmel: Advisory Panel; Spouse/Partner; Abbott, Becton, Dickinson and Company, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Merck & Co., Inc., Novo Nordisk Inc., Omada Health, Inc., OptumRx, Inc., Sanofi, Zafgen, Inc. Consultant; Self; MannKind Corporation. Research Support; Spouse/Partner; AstraZeneca, Dexcom, Inc., MannKind Corporation. Speaker's Bureau; Spouse/Partner; Novo Nordisk Inc. V.F. Ruelas: None. E.T. Nykaza: None. A.L. Peters: Advisory Panel; Self; Abbott, Becton, Dickinson and Company, Bigfoot Biomedical, Eli Lilly and Company, Lexicon Pharmaceuticals, Inc., Livongo Health, MannKind Corporation, Medscape, Merck & Co., Inc., Omada Health, Inc., OptumRx, Inc., Sanofi US, Zafgen, Inc. Research Support; Self; AstraZeneca, Dexcom, Inc., Jaeb Center for Health Research, MannKind Corporation, National Institute of Diabetes and Digestive and Kidney Diseases. Speaker's Bureau; Self; Novo Nordisk Inc.
Skip Nav Destination
Article navigation
P: Clinical Therapeutics/New Technology—Glucose Monitoring and Sensing|
June 01 2019
964-P: CGM-Tele Monitoring in Older Adults with T1D: Results of a Pilot Study
MARK D. HARMEL;
MARK D. HARMEL
Los Angeles, CA, Palo Alto, CA
Search for other works by this author on:
VALERIE F. RUELAS;
VALERIE F. RUELAS
Los Angeles, CA, Palo Alto, CA
Search for other works by this author on:
EDWARD T. NYKAZA;
EDWARD T. NYKAZA
Los Angeles, CA, Palo Alto, CA
Search for other works by this author on:
ANNE L. PETERS
ANNE L. PETERS
Los Angeles, CA, Palo Alto, CA
Search for other works by this author on:
Diabetes 2019;68(Supplement_1):964-P
Citation
MARK D. HARMEL, VALERIE F. RUELAS, EDWARD T. NYKAZA, ANNE L. PETERS; 964-P: CGM-Tele Monitoring in Older Adults with T1D: Results of a Pilot Study. Diabetes 1 June 2019; 68 (Supplement_1): 964–P. https://doi.org/10.2337/db19-964-P
Download citation file: